Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

BACKGROUND: The aim of this study was to assess the real-world effectiveness and safety of certolizumab pegol (CZP) in rheumatoid arthritis (RA) patients, and the impact on patients’ productivity, pain, and fatigue, in Canadian practice. METHODS: FαsT-CAN, a 2-year prospective, observational study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessette, Louis, Haraoui, Boulos, Chow, Andrew, Fortin, Isabelle, Dixit, Sanjay, Khraishi, Majed, Haaland, Derek, Elmoufti, Sami, Staelens, Fabienne, Bogatyreva, Irina, Syrotuik, Jerry, Shaikh, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402066/
https://www.ncbi.nlm.nih.gov/pubmed/30858896
http://dx.doi.org/10.1177/1759720X19831151

Ejemplares similares

Ejemplares similares